IRIS
PERRONE, MARIA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.770
EU - Europa 1.578
AS - Asia 948
SA - Sud America 49
OC - Oceania 9
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.360
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.739
CN - Cina 516
IT - Italia 471
SE - Svezia 386
SG - Singapore 257
DE - Germania 142
UA - Ucraina 133
RU - Federazione Russa 120
FI - Finlandia 97
ID - Indonesia 91
GB - Regno Unito 81
BE - Belgio 37
FR - Francia 31
BR - Brasile 30
CA - Canada 27
IN - India 24
IE - Irlanda 20
CZ - Repubblica Ceca 19
JP - Giappone 13
IR - Iran 12
NL - Olanda 12
CL - Cile 9
AU - Australia 8
VN - Vietnam 8
EG - Egitto 5
KR - Corea 5
CH - Svizzera 4
HK - Hong Kong 4
HU - Ungheria 4
PE - Perù 4
AR - Argentina 3
AT - Austria 3
BD - Bangladesh 3
BG - Bulgaria 3
ES - Italia 3
IL - Israele 3
IQ - Iraq 3
MX - Messico 3
TR - Turchia 3
GR - Grecia 2
LT - Lituania 2
PL - Polonia 2
RO - Romania 2
AM - Armenia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
LB - Libano 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 8.360
Salva come PNG Salva come JPEG
Città #
Fairfield 824
Chandler 605
Woodbridge 543
Houston 421
Ashburn 387
Nyköping 325
Seattle 324
Jacksonville 317
Cambridge 311
Ann Arbor 294
Wilmington 249
Singapore 193
Bari 181
Roxbury 108
Lawrence 107
Beijing 104
Nanjing 95
Sannicandro di Bari 82
New York 71
Boardman 61
Des Moines 61
Princeton 57
Dearborn 51
Inglewood 43
Jakarta 36
San Diego 36
Brussels 35
Brooklyn 33
Nanchang 30
Jiaxing 27
Hebei 24
Shenyang 24
Santa Clara 23
Changsha 20
Munich 20
Dublin 19
Shanghai 18
Brno 17
London 17
Milan 17
Toronto 14
Bitonto 13
Helsinki 12
Los Angeles 12
Paris 12
Frankfurt am Main 11
Wuhan 11
Tokyo 10
Washington 10
Ardabil 9
Falls Church 9
Hefei 9
Pune 9
Redwood City 9
Tianjin 9
Guangzhou 8
Norwalk 8
San Francisco 8
Augusta 7
Dong Ket 7
San Mateo 7
Santiago 7
Turin 7
Florence 6
Rome 6
São Paulo 6
Wuxi 6
Adelfia 5
Chicago 5
Grottaglie 5
Redmond 5
Adelaide 4
Arequipa 4
Cairo 4
Casoria 4
Chengdu 4
Edinburgh 4
Hong Kong 4
Indiana 4
Jinan 4
Kansas City 4
Kilburn 4
Kornye 4
Kunming 4
Lincoln 4
Marseille 4
Monmouth Junction 4
Ottawa 4
Valenzano 4
Valparaiso 4
Wallsend 4
Coimbatore 3
Detroit 3
Fano 3
Jinhua 3
Massafra 3
Napoli 3
Nuremberg 3
Racale 3
Reggio Emilia 3
Totale 6.579
Salva come PNG Salva come JPEG
Nome #
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 169
COX-1 Inhibitors: Beyond Structure Toward Therapy 132
4-Nitro-2,1,3-benzoxadiazole derivatives as potential fluorescent sigma receptor probes 129
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 126
Design and synthesis of fluorescent ligands for the detection of cannabinoid type 2 receptor (CB2R) 125
Screening yeasts for the stereoselective reduction of oxoester clofibrate analogues 124
General role of the amino and methylsulfamoyl groups in selective cyclooxygenase(COX)-1 inhibition by 1,4-diaryl-1,2,3-triazoles and validation of a predictive pharmacometric PLS model 121
Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6) 120
4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulators 119
Isoxazole-Based-Scaffold Inhibitors Targeting Cyclooxygenases (COXs) 119
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection 113
PET radiotracer [18F]-P6 selectively targeting COX-1 as a novel biomarker in ovarian cancer: Preliminary investigation 112
Zoledronic acid modulation of TRPV1 channel currents in osteoblast cell line and native rat and mouse bone marrow-derived osteoblasts: Cell proliferation and mineralization effect 108
Design, Biological Evaluation and Molecular Modelling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-glycoprotein Ligand Overcoming Multi-Drug Resistance in Cancer Stem Cells. 106
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators 106
Update on SAR studies toward new COX-1 selective inhibitors 102
Multi-drug-resistance-reverting agents: 2-aryloxazole and 2-arylthiazole derivatives as potent BCRP or MRP1 inhibitors 101
Highly Selective Cyclooxygenase-1 Inhibitors P6 and Mofezolac Counteract Inflammatory State both In Vitro and In Vivo Models of Neuroinflammation 101
Functionalized Coumarine Fragment to Obtain Fluorescent and Selective P-Glycoprotein Ligands 100
In vitro evaluation of glycol chitosan based formulations as oral delivery systems for efflux pump inhibition 100
Arylamino Esters As P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity 100
Selective cyclooxygenase-1 inhibition by P6 and gastrotoxicity: Preliminary investigation 98
Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers 98
Synthesis, Pharmacological Characterization, and Docking Analysis of a Novel Family of Diarylisoxazoles as Highly Selective Cyclooxygenase‑1 (COX-1) Inhibitors 97
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives 96
Baker's yeast-mediated reduction of ethyl 2-(4-chlorophenoxy)-3-oxoalkanoates intermediates for potential PPARa ligands 96
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands 96
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 95
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 94
Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells 93
Lipase-mediated kinetic resolution of rigid clofibrate analogues, with lipid-modifying activity 93
Current and emerging applications of fluorine in medicinal chemistry 93
Harmaline-based scaffold as Human Caseinolytic Protease P (hClpP) inducers for Diffuse Intrinsic Pontine Glioma (DIPG) treatment 92
Synthesis and Biological Evaluation of New Clofibrate Analogues as Potential PPARa Agonists 91
Synthesis and biological evaluation of 3-alkyloxazolidin-2-ones as reversible MAO inhibitors 89
Stereoselective Modulation of P-Glycoprotein by Chiral Small Molecules 88
Selective COX-1 inhibition: a therapeutic target to be reconsidered 87
A Benzopyrane derivative as P-glycoprotein stimulator: a potential agent to decrease beta-amyloid accumulation in Alzheimer’s disease 87
Kluyveromyces marxianus CBS 6556 growing cells as a new biocatalyst in the asymmetric reduction of substituted acetophenones 87
Naphthalenyl derivatives for hitting P-gp/MRP1/BCRP transporters 85
Exploring prospects of β3-adrenoceptor agonists and inverse agonists for colon motility control 83
Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues 82
Vascular Toxicity Risk Assessment of MC18 and MC70, Novel Potential Diagnostic Tools for In Vivo PET Studies 81
Structure-Activity Relationship Studies on 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Multidrug Resistance Reversers. 81
Modulation and absorption of xenobiotics: the synergistic role of CYP450 and P-gp activities in cancer and neurodegenerative disorders 80
The tertiary amine nitrogen atom of piperazine sulfonamides as a novel determinant of potent and selective beta3-adrenoceptor agonists 79
Novel pyrazoles and their radiolabeled derivatives useful as COX-1 selective inhibitors 78
Diastereo- and enantio-selective bioreduction of ethyl 2-(4-chlorophenoxy)-3-oxobutanoate clofibrate analogues by Kluyveromyces marxianus and other whole cell biocatalysts 77
A chemoenzymatic scalable route to optically active (R)-1-(pyridin-3-yl)-2-aminoethanol, valuable moiety of beta3-adrenergic receptor agonists 75
Bioethanol from biomass model fermentation by Kluyvromyces marxianus CBS6556 74
Beta 3-adrenoceptor ligand development history through patent review 74
Beta 3-Adrenoceptor Agonists and (Antagonists as) Inverse Agonists: History, Perspective, Constitutive Activity, and Stereospecific Binding 70
null 69
A Potent and Selective P-gp Modulator for Altering Multidrug Resistance Due to Pump Overexpression 69
An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid 65
Reaction of caesium 4-chlorophenate and chlorohydrins from threonines: synthesis of clofibrate analogues 64
null 64
Selective COX-1 inhibition as a target of theranostic novel diarylisoxazoles 64
NOVEL BISPHOSPHONATES, WITH ANTIRESORPTIVE EFFECT IN BONE MINERALIZATION AND OSTEOCLASTOGENESIS, AS MOIETIES OF RA 223-BASED RADIOTRACERS 64
Diffuse Intrinsic Pontine Glioma (DIPG): breakthrough and clinical perspective 63
Highly selective COX-1 inhibitors as novel cardioprotective anti-thrombotic agents 62
BETA-3 RECEPTOR LIGANDS AND THEIR USE IN THERAPY 62
Selective κ Opioid Antagonists nor-BNI, GNTI and JDTic Have Low Affinities for Non-Opioid Receptors and Transporters 62
Acridone derivatives and small molecules as P-gp inhibitors 61
Activity-lipophilicity relationship studies on P-gp ligands designed as simplified tariquidar bulky fragments 61
6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers 61
Ligandi del recettore beta-3 adrenergico e loro uso in terapia 59
[18F]-P6 AS A CYCLOOXYGENASE-1 TARGETED IMAGING AGENT 58
Lipid-modifying agents by yeasts- and a novel ADH-mediated reduction of 3-oxoesters 58
Substrates, inhibitors and activators of P-glycoprotein: candidates for radiolabeling and imaging perspectives 58
Lipid-modifying agents by yeasts- and a novel ADH-mediated reduction of 3-oxoesters 56
Up-regulation of b3-adrenergic receptor mRNA in human colon cancer: a preliminary study 56
A Combined HPLC and LC-MS Approach for Evaluating Drug Stability in Elastomeric Devices: A Challenge for the Sustainability in Pharmacoeconomics 56
Mucoadhesive Properties and Interaction with P-glycoprotein (P-gp) of Thiolated-Chitosans and -Glycol Chitosans and Corresponding Parent Polymers: A Comparative Study 55
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 55
MC225, a Novel Probe for P-glycoprotein PET imaging at the Blood-Brain Barrier: in vitro cardivascular safety evaluation 54
CYP3A4/P-gp sinergistic activity to modulate the absorption and delivery of xenobiotics 53
Bioassisted synthesis of 3-hydroxyacids resembling antilipidemic clofibric acid molecular structure 53
CLC-K kidney chloride channels as drug target for hypertension: effects of acute in vivo administration to rats of newly synthesized inhibitors 53
Isoxazole and pyrazole core in COX-1 inhibitors 52
Yeast and a novel ADH-mediated biosynthesis of new clofibrate analogues 52
Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders 52
SAR study on Arylmethyloxyphenyl scaffold: looking for a P-gp nanomolar affinity 51
Myogenic effect of SP-1f and SP-1h two novel 3-adrenoceptor (3-AR) agonists in human colonic circular smooth muscle 50
Three-dimensional structure of human cyclooxygenase (hCOX)-1 49
β 3 -Adrenoceptor agonists and (Antagonists as) inverse agonists. History, perspective, constitutive activity, and stereospecific binding 48
null 48
Neuroinflammation and Microglial Constitutive COX-1 Inhibition 46
null 45
Why PB28 Could Be a Covid 2019 Game Changer? 45
In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: A new drug target for hypertension? 45
Method of screening for therapeutic compounds useful in detoxifying central nervous system from beta-amyloid peptide 44
Enantioselective bio-reduction of prochiral ketones by the non-conventional yeast Kluyveromyces marxianus 44
Effects of carvacrol, a major constituents of origanum essential oil, on the central nervous system of male rats 44
Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease 44
Ovine COX-1 Isoenzyme Bio-production 43
Receptor drug interaction: europium employment for studying the biochemical pathway of GPRC activation 42
Selective inhibition of cyclooxygenase (COX) isoenzymes and neuroinflammation 41
Synthesis and pharmacological characterization of new beta 3-adrenergic agonists?? 41
null 41
Totale 7.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.459
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.027 0 0 0 0 0 0 197 169 219 183 187 72
2020/20211.223 141 75 118 79 123 40 80 88 120 183 113 63
2021/2022933 77 113 23 18 41 70 49 50 67 77 129 219
2022/20231.569 202 187 139 123 184 207 15 188 236 21 42 25
2023/2024771 40 96 48 66 55 109 43 22 122 47 22 101
2024/2025899 121 34 208 93 126 221 96 0 0 0 0 0
Totale 8.894